Company · CIK 1933414
Mineralys Therapeutics, Inc.
| CIK | 1933414 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | PA |
| Listed | MLYS (Nasdaq) |
| First annual or quarterly report | 2023-03-15 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291435 | 2025-11-10 | 2026-06-03 | 2 | |
| 333-278122 | 2024-03-21 | 2025-09-03 | 7 | |
| 333-269282 | 2023-01-18 | 2023-02-10 | 4 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-03 | 424B5Shelf takedown | 333-291435 | 0001628280-26-040216 |
| 2025-11-10 | S-3ASRShelf registered | 333-291435 | 0001933414-25-000144 |
| 2025-09-03 | 424B5Shelf takedown | 333-278122 | 0001933414-25-000119 |
| 2025-09-02 | 424B5Shelf takedown | 333-278122 | 0001933414-25-000103 |
| 2025-03-12 | 424B5Shelf takedown | 333-278122 | 0001628280-25-012332 |
| 2025-03-10 | 424B5Shelf takedown | 333-278122 | 0001628280-25-011640 |
| 2024-04-11 | EFFECTDeclared effective | 333-278122 | 9999999995-24-000936 |
| 2024-04-11 | 424B5Shelf takedown | 333-278122 | 0001628280-24-015841 |
| 2024-03-21 | S-3Shelf registered | 333-278122 | 0001628280-24-012362 |
| 2023-02-10 | 424B4Final prospectus | 333-269282 | 0001628280-23-003159 |
| 2023-02-09 | EFFECTDeclared effective | 333-269282 | 9999999995-23-000353 |
| 2023-02-02 | S-1/AAmendment | 333-269282 | 0001628280-23-001963 |
| 2023-01-18 | S-1Registration filed | 333-269282 | 0001628280-23-001171 |
| 2022-11-04 | DRSDraft made public | 377-06446 | 0001628279-22-000451 |